Pharmacokinetics, Pharmacodynamics, and Safety of Nivolumab in Patients With Sepsis-Induced Immunosuppression: A Multicenter, Open-Label Phase 1/2 Study - Concepedia

Concepedia

Publication | Open Access

Pharmacokinetics, Pharmacodynamics, and Safety of Nivolumab in Patients With Sepsis-Induced Immunosuppression: A Multicenter, Open-Label Phase 1/2 Study

DOI Full Paper Access

60

Citations

38

References

2019

Year

Eizo Watanabe, Osamu Nishida, Yasuyuki Kakihana, Motoi Odani, Tatsuaki Okamura, Tomohiro Harada, Shigeto Oda

Abstract

JAPIC, JapicCTI-173600.

References

	Year	Citations

Page 1